Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy Patients

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 20, 2024

Primary Completion Date

December 10, 2025

Study Completion Date

December 20, 2025

Conditions
LeprosyMycobacterium Leprae Infection
Interventions
DRUG

Dapsone

To evaluate the effect of the multi drug therapy in leprotic patients and their side effects and to assess the role of Rab 32 gene in leprosy prognosis and to know its association with the multi drug therapy.

Trial Locations (1)

Unknown

RECRUITING

Qina University hospital, South Valley University Hospital, Qina

All Listed Sponsors
lead

South Valley University

OTHER